Ruiz Israel 4
4 · Moderna, Inc. · Filed Dec 13, 2018
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Ruiz Israel
Director
Transactions
- Conversion
Common Stock
2018-12-11+4,559→ 4,559 total - Conversion
Series G Preferred Stock
2018-12-11−4,559→ 0 total→ Common Stock (4,559 underlying)
Footnotes (1)
- [F1]The Series G Preferred Stock (the "Preferred Stock") converted into Common Stock based on an applicable conversion ratio of 0.45872 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date.